Functional Analysis of Histone Demethylase Activity in Hypoxic Cancer Cells

缺氧癌细胞中组蛋白去甲基化酶活性的功能分析

基本信息

  • 批准号:
    8534219
  • 负责人:
  • 金额:
    $ 21.86万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY (See instructions): Uncontrolled cell growth within a tumor results in hypoxia as the metabolic needs of the cells exceed the ability of the tumor vasculature to provide oxygen and nutrients. In response to the hypoxic microenvironment, cells undergo a massive reprogramming of transcription to promote survival. The Hypoxia Inducible Transcription Factors (HIFs) are primary regulators of the hypoxic response and induce the expression of glycolytic genes, cell migration factors, and angiogenic factors. HIFs also induce expression of several transcriptional regulators, including several histone demethylases, providing a mechanism for the hypoxic cell to extend or fix the expression of pro-survival genes. One of these histone demethylases, JMJD2B, demethylates tri-methylated histone H3 lysine 9 (H3K9me3), a key marker of repressed chromatin structure. Hypoxic induction of JMJD2B may play an important role in activating gene expression to promote tumor growth. Consistent with this hypothesis, forced knock-down of JMJD2B expression reduces growth of tumor xenografts, and is overexpressed in ovarian cancers. In this proposal, the extent to which JMJD2B regulates tumor growth will be tested in vivo using tumor xenograft experiments and in vitro by assaying for cell proliferation, invasion, and angiogenesis as a result of JMJD2B expression (Specific Aim 1). Subsequent biochemical experiments will determine the mechanism of specific target gene regulation in hypoxia, identify new genes regulated by JMJD2B in hypoxia, and characterize the regulation of key pathways of genes important for the tumorigenic phenotype (Specific Aim 2). The experiments described in this proposal will establish the mechanisms utilized by JMJD2B to regulate tumorigenesis, while identifying new pathways to target for enhanced tumor therapies.
项目总结(见说明): 肿瘤内不受控制的细胞生长导致缺氧,因为细胞的代谢需求超过了肿瘤脉管系统提供氧气和营养物的能力。为了应对缺氧微环境,细胞进行大规模的转录重编程以促进存活。缺氧诱导转录因子(HIF)是缺氧反应的主要调节因子,并诱导糖酵解基因、细胞迁移因子和血管生成因子的表达。HIF还诱导几种转录调节因子的表达,包括几种组蛋白脱甲基酶,为缺氧细胞提供延长或固定促存活基因表达的机制。这些组蛋白去甲基化酶之一JMJD2B使三甲基化组蛋白H3赖氨酸9(H3K9me3)去甲基化,这是被抑制的染色质结构的关键标志物。缺氧诱导JMJD 2B可能在激活基因表达以促进肿瘤生长方面发挥重要作用。与该假设一致,JMJD2B表达的强制敲低降低了肿瘤异种移植物的生长,并且在卵巢癌中过表达。在该提议中,将使用肿瘤异种移植实验在体内测试JMJD2B调节肿瘤生长的程度,并通过测定JMJD2B表达导致的细胞增殖、侵袭和血管生成在体外测试JMJD2B调节肿瘤生长的程度(特异性目的1)。随后的生化实验将确定缺氧中特定靶基因调控的机制,鉴定缺氧中JMJD2B调控的新基因,并表征对致瘤表型重要的基因的关键途径的调控(特异性目的2)。本提案中描述的实验将建立JMJD2B用于调节肿瘤发生的机制,而 为增强肿瘤治疗寻找新的靶向途径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ADAM J KRIEG其他文献

ADAM J KRIEG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ADAM J KRIEG', 18)}}的其他基金

Anti-Mullerian Hormone Actions to Control Primate Folliculogenesis
抗苗勒氏管激素作用控制灵长类动物毛囊发生
  • 批准号:
    10293067
  • 财政年份:
    2015
  • 资助金额:
    $ 21.86万
  • 项目类别:
Anti-Mullerian Hormone Actions to Control Primate Folliculogenesis
抗苗勒氏管激素作用控制灵长类动物毛囊发生
  • 批准号:
    10700008
  • 财政年份:
    2015
  • 资助金额:
    $ 21.86万
  • 项目类别:
ANALYSIS OF HISTONE DEMETHYLASE ACTIVITY IN HYPOXIC CANCER CELLS
缺氧癌细胞中组蛋白去甲基酶活性的分析
  • 批准号:
    8360685
  • 财政年份:
    2011
  • 资助金额:
    $ 21.86万
  • 项目类别:
Mechanisms of transcriptional repression by p53 during hypoxic stress
缺氧应激期间 p53 转录抑制的机制
  • 批准号:
    7276847
  • 财政年份:
    2007
  • 资助金额:
    $ 21.86万
  • 项目类别:
Mechanisms of transcriptional repression by p53 during hypoxic stress
缺氧应激期间 p53 转录抑制的机制
  • 批准号:
    7744004
  • 财政年份:
    2007
  • 资助金额:
    $ 21.86万
  • 项目类别:
Mechanisms of transcriptional repression by p53 during hypoxic stress
缺氧应激期间 p53 转录抑制的机制
  • 批准号:
    7515446
  • 财政年份:
    2007
  • 资助金额:
    $ 21.86万
  • 项目类别:
Functional Analysis of Histone Demethylase Activity in Hypoxic Cancer Cells
缺氧癌细胞中组蛋白去甲基化酶活性的功能分析
  • 批准号:
    8480350
  • 财政年份:
  • 资助金额:
    $ 21.86万
  • 项目类别:
Functional Analysis of Histone Demethylase Activity in Hypoxic Cancer Cells
缺氧癌细胞中组蛋白去甲基化酶活性的功能分析
  • 批准号:
    8691928
  • 财政年份:
  • 资助金额:
    $ 21.86万
  • 项目类别:
Functional Analysis of Histone Demethylase Activity in Hypoxic Cancer Cells
缺氧癌细胞中组蛋白去甲基化酶活性的功能分析
  • 批准号:
    8922032
  • 财政年份:
  • 资助金额:
    $ 21.86万
  • 项目类别:

相似海外基金

How angiogenic factor induces immunosuppressive cells to tumor microenvironment
血管生成因子如何诱导免疫抑制细胞进入肿瘤微环境
  • 批准号:
    22KJ0818
  • 财政年份:
    2023
  • 资助金额:
    $ 21.86万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
  • 批准号:
    10711027
  • 财政年份:
    2021
  • 资助金额:
    $ 21.86万
  • 项目类别:
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
  • 批准号:
    10297199
  • 财政年份:
    2021
  • 资助金额:
    $ 21.86万
  • 项目类别:
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
  • 批准号:
    10625314
  • 财政年份:
    2021
  • 资助金额:
    $ 21.86万
  • 项目类别:
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the Brain
腺苷琥珀酸作为大脑中新型内源性促血管生成因子的验证
  • 批准号:
    10405070
  • 财政年份:
    2021
  • 资助金额:
    $ 21.86万
  • 项目类别:
Physiological role of anti-angiogenic factor thrombospondin in the regulation of endometrial function during early pregnancy in cattle
抗血管生成因子血小板反应蛋白在牛妊娠早期子宫内膜功能调节中的生理作用
  • 批准号:
    20K06385
  • 财政年份:
    2020
  • 资助金额:
    $ 21.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of lymphangiogenic regulatory mechanism of angiogenic factor CCN2 through tumor-associated macrophage
阐明血管生成因子CCN2通过肿瘤相关巨噬细胞的淋巴管生成调节机制
  • 批准号:
    17K11866
  • 财政年份:
    2017
  • 资助金额:
    $ 21.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of vascular stabilization mechanism by anti-angiogenic factor vasohibin-1
抗血管生成因子 vasohibin-1 阐明血管稳定机制
  • 批准号:
    15K20874
  • 财政年份:
    2015
  • 资助金额:
    $ 21.86万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
angiogenic therapy for cerebral infarction with anti^sense homology derived peptide targeting angiogenic factor
靶向血管生成因子的反义同源肽治疗脑梗死
  • 批准号:
    15K15523
  • 财政年份:
    2015
  • 资助金额:
    $ 21.86万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
The development of the anti-angiogenic factor VEGF-A165b quantification methods for cardiovascular disease.
心血管疾病抗血管生成因子 VEGF-A165b 定量方法的开发。
  • 批准号:
    26860367
  • 财政年份:
    2014
  • 资助金额:
    $ 21.86万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了